274 related articles for article (PubMed ID: 33667562)
1. A review on liposome-based therapeutic approaches against malignant melanoma.
Mirzavi F; Barati M; Soleimani A; Vakili-Ghartavol R; Jaafari MR; Soukhtanloo M
Int J Pharm; 2021 Apr; 599():120413. PubMed ID: 33667562
[TBL] [Abstract][Full Text] [Related]
2. Liposome-based diagnostic and therapeutic applications for pancreatic cancer.
Raza F; Evans L; Motallebi M; Zafar H; Pereira-Silva M; Saleem K; Peixoto D; Rahdar A; Sharifi E; Veiga F; Hoskins C; Paiva-Santos AC
Acta Biomater; 2023 Feb; 157():1-23. PubMed ID: 36521673
[TBL] [Abstract][Full Text] [Related]
3. Peptide-modified vemurafenib-loaded liposomes for targeted inhibition of melanoma via the skin.
Zou L; Ding W; Zhang Y; Cheng S; Li F; Ruan R; Wei P; Qiu B
Biomaterials; 2018 Nov; 182():1-12. PubMed ID: 30096444
[TBL] [Abstract][Full Text] [Related]
4. Oestrogen receptor-mediated liposomal drug delivery for treating melanoma.
Ganguly A; Rachamalla HKR; Bhattacharya D; Bhamidipati K; Pal A; Gora Ravuri H; Chakravarty S; Adhikari SS; Banerjee R
J Drug Target; 2018; 26(5-6):481-493. PubMed ID: 29376759
[TBL] [Abstract][Full Text] [Related]
5. Nanotechnology-empowered strategies in treatment of skin cancer.
Chandra J; Hasan N; Nasir N; Wahab S; Thanikachalam PV; Sahebkar A; Ahmad FJ; Kesharwani P
Environ Res; 2023 Oct; 235():116649. PubMed ID: 37451568
[TBL] [Abstract][Full Text] [Related]
6. Liposomes in the treatment of malignancy: a clinical perspective.
Sugarman SM; Perez-Soler R
Crit Rev Oncol Hematol; 1992; 12(3):231-42. PubMed ID: 1497823
[TBL] [Abstract][Full Text] [Related]
7. Liposome technologies towards colorectal cancer therapeutics.
Sang R; Stratton B; Engel A; Deng W
Acta Biomater; 2021 Jun; 127():24-40. PubMed ID: 33812076
[TBL] [Abstract][Full Text] [Related]
8. Novel Nanolipoidal Systems for the Management of Skin Cancer.
Singh A; Nimisha
Recent Pat Drug Deliv Formul; 2020; 14(2):108-125. PubMed ID: 32807069
[TBL] [Abstract][Full Text] [Related]
9. Translational Research in Cutaneous Melanoma: New Therapeutic Perspectives.
Marra A; Ferrone CR; Fusciello C; Scognamiglio G; Ferrone S; Pepe S; Perri F; Sabbatino F
Anticancer Agents Med Chem; 2018; 18(2):166-181. PubMed ID: 29256359
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in targeted nanoparticles drug delivery to melanoma.
Li J; Wang Y; Liang R; An X; Wang K; Shen G; Tu Y; Zhu J; Tao J
Nanomedicine; 2015 Apr; 11(3):769-94. PubMed ID: 25555352
[TBL] [Abstract][Full Text] [Related]
11. Cancer stem cells-emanated therapy resistance: Implications for liposomal drug delivery systems.
Dianat-Moghadam H; Heidarifard M; Jahanban-Esfahlan R; Panahi Y; Hamishehkar H; Pouremamali F; Rahbarghazi R; Nouri M
J Control Release; 2018 Oct; 288():62-83. PubMed ID: 30184466
[TBL] [Abstract][Full Text] [Related]
12. Peptide-functionalized liposomes as therapeutic and diagnostic tools for cancer treatment.
Sonju JJ; Dahal A; Singh SS; Jois SD
J Control Release; 2021 Jan; 329():624-644. PubMed ID: 33010333
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Phase Transition Temperature on Therapeutic Efficacy of Liposomal Bortezomib.
Korani M; Nikoofal-Sahlabadi S; Nikpoor AR; Ghaffari S; Attar H; Mashreghi M; Jaafari MR
Anticancer Agents Med Chem; 2020; 20(6):700-708. PubMed ID: 31893998
[TBL] [Abstract][Full Text] [Related]
14. Nano-drug delivery system targeting tumor microenvironment: A prospective strategy for melanoma treatment.
Xu M; Li S
Cancer Lett; 2023 Oct; 574():216397. PubMed ID: 37730105
[TBL] [Abstract][Full Text] [Related]
15. Research progress on hydrogel-based drug therapy in melanoma immunotherapy.
He W; Zhang Y; Qu Y; Liu M; Li G; Pan L; Xu X; Shi G; Hao Q; Liu F; Gao Y
BMB Rep; 2024 Feb; 57(2):71-78. PubMed ID: 38053295
[TBL] [Abstract][Full Text] [Related]
16. Use of liposomes as drug delivery vehicles for treatment of melanoma.
Tran MA; Watts RJ; Robertson GP
Pigment Cell Melanoma Res; 2009 Aug; 22(4):388-99. PubMed ID: 19493316
[TBL] [Abstract][Full Text] [Related]
17. Recent advances and clinical translation of liposomal delivery systems in cancer therapy.
Chen J; Hu S; Sun M; Shi J; Zhang H; Yu H; Yang Z
Eur J Pharm Sci; 2024 Feb; 193():106688. PubMed ID: 38171420
[TBL] [Abstract][Full Text] [Related]
18. Liposomal drug delivery systems--clinical applications.
Goyal P; Goyal K; Vijaya Kumar SG; Singh A; Katare OP; Mishra DN
Acta Pharm; 2005 Mar; 55(1):1-25. PubMed ID: 15907221
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticle-mediated drug delivery for treating melanoma.
Mundra V; Li W; Mahato RI
Nanomedicine (Lond); 2015; 10(16):2613-33. PubMed ID: 26244818
[TBL] [Abstract][Full Text] [Related]
20. Advances in encapsulated dermal formulations in chemoprevention of melanoma: An overview.
Ravikumar P; Tatke P
J Cosmet Dermatol; 2019 Dec; 18(6):1606-1612. PubMed ID: 31436386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
